Co-Founder Skin & Digital Summit
Professor of Dermatology, Pathology, Social Sciences & Health Policy
Wake Forest University School of Medicine
Senior Advisor, Dermatology & Patient Adherence
Professor, Vice Chair & Residency Program Director
Department of Dermatology
Yale School of Medicine
Waldman Professor and System Chair, Department of Dermatology
Director, Center of Excellence in Eczema
Director, Laboratory of Inflammatory Skin Diseases
Icahn School of Medicine at Mount Sinai
Professor and Chair, Department of Dermatology
Director, Autoimmune Therapeutics Institute
Director, Vitiligo Clinic and Research Center
UMass Chan Medical School
Chief of Medical Dermatology
Associate Chief Quality Officer
Clinical Lead, Patient Experience
Stanford Health Care
Clinical Professor, Department of Dermatology
Stanford University School of Medicine
Supervisory Physician & Director
Founder, Executive Chairman & Chief Scientific Officer
Assistant Professor of Dermatology
Professor of Dermatology & Director of the Penn Clinical Autoimmunity Center of Excellence
University of Pennsylvania
Senior Medical Director, Clinical Development
Assistant Professor, Dermatology
co-Director, Oncodermatology Program
Massachusetts General Hospital and Harvard Medical School
Senior Vice President, Clinical Development
Chief Executive Officer
* Presentation order subject to change
Emma Guttman-Yassky, MD, PhD, Waldman Professor & System Chair, Department of Dermatology;
Director, Center of Excellence in Eczema; Director, Laboratory of Inflammatory Skin Diseases,
Icahn School of Medicine at Mount Sinai
Innovations in Topical Drug Products
Chair: Vijendra Nalamothu, PhD, Executive Chairman & Chief Scientific Officer, Tergus Pharma
Steven R. Feldman, MD, PhD, Professor of Dermatology, Pathology, Social Sciences & Health Policy, Wake Forest University School of Medicine; Senior Advisor, Dermatology & Patient Adherence, Sensal Health
Markham Luke, MD, PhD, FAAD, Supervisory Physician & Director, FDA
Emerging Digital Technologies for Clinical Trials in Dermatology
Chair: Steve Xu MD, MSc, FAAD, Chief Executive Officer, Sibel Health
Art Papier, MD, FAAD, Co-founder and Chief Executive Officer, VisualDx
Strategies in the Regulation of Cutaneous Inflammation
Chair: Michael Girardi, MD, FAAD, Professor, Vice Chair & Residency Program Director
Department of Dermatology, Yale School of Medicine
John E. Harris, MD, PhD, Professor and Chair, Department of Dermatology; Director of Vitiligo Clinic and Research Center, UMass Chan Medical School
Ian Odell, MD, PhD, FAAD, Assistant Professor of Dermatology, Yale University
Aimee S. Payne, MD, PhD, Professor of Dermatology & Director of the Penn Clinical Autoimmunity Center of Excellence, University of Pennsylvania
Bhaskar Srivastava, MD, PhD, Senior Vice President, Clinical Development, Nimbus Therapeutics
Re-Establishing Immune Tolerance
Chair: Adam Raff, MD, PhD, FAAD, Senior Medical Director, EQRx
Paul Klekotka, MD, PhD, FAAD, Associate Vice President, Immunology, Lilly Research Laboratories
Paul F. Lizzul, MD, PhD, MPH, MBA, Chief Medical Officer, AnaptysBio
Skin & Digital Summit with Magic Wand Initiative
Chair: Dominique Du Crest, Founder, SKINAID, Co-Founder Skin & Digital Summit
Lilit Garibyan, MD, PhD, FAAD, Assistant Professor of Dermatology, Harvard Medical School; Co-Founder Magic Wand Initiative
Justin M. Ko, MD, MBA, FAAD, Chief of Medical Dermatology, Associate Chief Quality Officer, Clinical Lead, Patient Experience, Stanford Health Care; Clinical Professor, Department of Dermatology, Stanford University School of Medicine
Eugene Semenov MD, MA, FAAD, Assistant Professor of Dermatology, Harvard Medical School
Chief Executive Officer
Associate Clinical Professor of Medicine, Division of Dermatology
David Geffen School of Medicine at UCLA
President & Founding Trustee
Advancing Innovation in Dermatology, Inc.
Pharus Advisors, LLC
Professor & Chair of Dermatology
NYU Grossman School of Medicine
Chief Corporate Development Officer
Senior Medical Director
Dermatology Innovation Forum utilizes a conference app for meeting materials and networking, available on both Apple and Android devices for all registered attendees.
Our app will launch in February, and you will receive an email at that time with instructions.
What is the agenda for the conference?
The current program agenda can be found here.
What is the cost of registration?
If registered by February 17, 2023 – $185 Physicians and Academicians / $445 Industry
Registration after February 17, 2023 – $245 Physicians and Academicians / $595 Industry
What is included in the registration fees?
Conference registration includes:
Health and Safety Release
Advancing Innovation in Dermatology, Inc. (“AID”) looks forward to welcoming attendees back in person for the 2023 Dermatology Innovation Forum scheduled for March 16, 2023. Health and safety remain a top priority, and AID is working with the venue to plan for on-site precautions and mitigations for the event, including related to COVID-19. Attendees should follow the CDC’s Isolation and Precautions for People with COVID-19 guidance, if they have tested positive for COVID-19 for any test done on or after March 5, 2023, or if they experienced symptoms of COVID-19 on or after March 5, 2023.
In all events, attendees must follow all federal, state and local health and safety guidance, including guidance on when to quarantine and wear a mask (AID reserves the right to update its health and safety policies in its discretion from to time to time). Of course, given the highly contagious nature of COVID-19 and its ability to spread by person-to-person contact, the event carries a risk of exposure to COVID-19 to attendees. By attending the event, attendees hereby agree to accept such risk and release and waive any and all claims, now known or hereafter known, against AID, its officers, directors, trustees, employees and agents, as well as its successors and assigns (collectively, the Releasees”) on account of any exposure to COVID-19 or any other illness or infection that may be associated with the event caused by any of the Releasees (except claims for willful misconduct or liability that cannot be released by applicable law).
How do I become a Sponsor?
If you are interested in a sponsorship opportunity, please contact Amanda Pacia at email@example.com, for the sponsorship overview and level pricing.
I am a confirmed speaker, now what?
Please check back for confirmed speaker deliverables or contact Faye Silag at firstname.lastname@example.org.
What is the dress code?
Attire is business casual. Feel free to be comfortable in slacks, polo shirts, blazers, blouses and most importantly, comfortable shoes. We do recommend you dress in layers as temperatures in meeting rooms can vary.
I am a Sponsor. How do I redeem my contracted complimentary registration(s)?
After your sponsorship has been processed, you will receive an email with a unique code and instructions to register online. We encourage all complimentary and discounted registrations to be completed by February 17, 2023. If you have not yet received the email, please contact Faye Silag at email@example.com.
Requests for registration fee cancellations for the conference must be received on or before February 24, 2023. At the discretion of the conference organizers, a refund via the method of original payment, minus a $125 non-refundable administrative fee, will be issued. No refunds will be made if notice is received after 3pm Eastern Time on February 24, 2023. Written notice of your cancellation should be sent to firstname.lastname@example.org with a copy to email@example.com.
No damages or refunds shall be due for a failure of performance or because of a delay or cancellation of one or more of the AID Initiatives by the occurrence of any contingency beyond the reasonable control of Host. These contingencies include, without limitation, threat of or actual war, terrorism, sabotage, insurrection, riot or other act of civil disobedience, act of public enemy, strikes, labor disputes, picketing or work stoppage (actual or threatened), an epidemic, pandemic or disease, act of government or any agency affecting the terms of this Agreement, accident, fire, explosion, flood, severe weather, natural disaster, or other act of God, change in meeting app ownership or management company, technology updates to the meeting app, interruptions or failure of the Internet, accessibility, connectivity or network connections, or any other acts beyond the reasonable control of the responsible parties.